Reviews in Medical Virology
© John Wiley & Sons Ltd
Edited By: Professor Paul Griffiths
Impact Factor: 5.574
ISI Journal Citation Reports © Ranking: 2014: 4/33 (Virology)
Online ISSN: 1099-1654
Effective with the 2014 volume, this journal will be published in an online-only format. No printed edition will be published. Articles will therefore appear online-only. All normal author benefits and services remain in place e.g. authors will continue to be able to order print reprints of articles if required. Furthermore, there will be no cost to authors for the publication of colour images in the online-only edition.
1. MANUSCRIPT CATEGORIES
- Reviews — Review articles will typically be solicited by the Editors. Authors who wish to submit an unsolicited review should first contact the appropriate Editor (via e-mail) to determine its suitability for publication in the Journal. All reviews will be peer-reviewed. Reviews should not exceed 4500 words of body text, and are limited to 150 references. On publication, the corresponding author of review articles will receive a complimentary online subscription to Reviews in Medical Virology (for personal use only).
- Classic papers —The Journal regularly reproduces key historical papers, accompanied with an expert commentary revisiting the results, and discussing their impact in the context of modern virology. Suggestions for classic papers should be forwarded to the Editor-in-Chief. Unsolicited submissions will not be considered.
- Forum debate —When necessary, the Journal will commission a series of conflicting articles examining a controversial topic from different viewpoints. Suggestions for topics to be debated in this way are encouraged, and should be forwarded to the Editor-in-Chief.
2. MANUSCRIPT SUBMISSION
All manuscripts should be submitted electronically via ScholarOne Manuscripts.
Authors must also supply:
Permission letters— it is the author’s responsibility to obtain written permission to reproduce (in all media, including electronic) material which has appeared in another publication.
Submission of a manuscript will be held to imply that it contains original unpublished work and is not under consideration for publication elsewhere at the same time.
3. EDITORIAL OFFICE
For all Editorial Office queries, please contact Cherrylyn Arenga - RMVedoffice@wiley.com
4. MANUSCRIPT PREPARATION
Manuscripts must be written in English.
Text should be supplied in a format compatible with Microsoft Word for Windows (PC). Charts and tables are considered textual and should also be supplied in a format compatible with Word. All figures (illustrations, diagrams, photographs) should be supplied in jpg, tiff or eps format.
All manuscripts must be typed in 12pt font and in double space with margins of at least 2.5 cm.
Manuscripts must include:
- Title Page . This should contain the article title, a running head not exceeding 50 characters (including spaces), 2–6 keywords and full contact details of the authors. One corresponding author should be identified, whose email address is provided.
- Summary . Authors submitting review papers should note that a summary of up to 250 words are required. The summary should outline the questions investigated, the design, essential findings and main conclusions of the study. It should contain no citations to other published work.
- Abbreviations . All abbreviations must be defined in the text on first use. Please supply a list of these abbreviations. Please click here for a list of abbreviations which can be used without prior definition
- Tables and Figures . Tables and figures should be referred to in text as follows: Figure 1, Figure 2; Table 1, Table 2. The place at which a table or figure is to be inserted in the printed text should be indicated clearly on a manuscript. Each table and/or figure must have a legend that explains its purpose without reference to the text.
- References . References should be indicated in the text with Arabic numbers inside square brackets, e.g., , [1,2] or [1–3]. The full references should be listed numerically in order of appearance, and presented following the text of the manuscript.
The Journal uses the following conventions for references:
- Niederau C, Heintges TM, Lange S, et al. Long-term follow-up of HbeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334: 1422–1427. DOI: 10.1002/ejm.258
- Jeffery K, Pillay D. Diagnostic approaches. In Principles and Practice of Clinical Virology, Zuckerman AJ, Banatvala JE, Pattison JR, Griffiths PD, Schoub BD (eds). John Wiley & Sons: Chichester, 2004; 1–21.
- Carter J, Saunders V. Virology: Principles and Applications . John Wiley & Sons: Chichester, 2007.
- All the Virology. http://www.virology.net/ [1 January 2007].
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper. The corresponding author MUST submit a Copyright Transfer Agreement as it is a requirement for publication.
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed by clicking the link below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp
OnlineOpen - The Open Access Option for Authors
OnlineOpen is available to authors who wish to make their article open access, free to read, download and share via Wiley Online Library and PubMed Central. Learn more here.
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
6. PUBLICATION ETHICS
Reviews in Medical Virology encourages its contributors and reviewers to adopt the standards of the International Committee of Medical Journal Editors. The journal will not consider papers that have been accepted for publication or published elsewhere. The Editors reserve the right to reject a paper on ethical grounds.
For more detailed ethical guidelines please visit: http://www.blackwellpublishing.com/Publicationethics/.
Conflict of interest
Authors are required to disclose financial interests in any company or institution that might benefit from their publication. A competing interest exists when a primary interest (such as patients’ welfare or the validity of research) might be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors of a Reviews in Medical Virology paper when they have a financial interest that may influence their interpretation of their results or those of others. Financial interests are the easiest to define and they have the greatest potential to influence the objectivity, integrity or perceived value of a publication. They may include any or all, but are not limited to, the following:
• Personal financial interests: Stocks or shares in companies that may gain or lose financially through publication; consultant fees or fees from speakers bureaus other forms of remuneration from organisations that may gain or lose financially; patents or patent applications whose value may be affected by publication.
• Funding: Research support from organisations that might gain or lose financially through publication of the paper.
• Employment: Recent, present or anticipated employment of you or a family member by any organization that may gain or lose financially through publication of the paper. Any such competing interest that authors may have should be declared. The aim of the statement is not to eradicate competing interests, as they are almost inevitable. Papers will not be rejected because there is a competing interest, but a declaration on whether or not there are competing interests will be added to the paper.
• Patent rights
• Consultancy work.
All authors must disclose competing interests, or state “none” via the Journal's ScholarOne Manuscripts website.
Plagiarism and falsification of data
The Journal carefully scrutinises papers for evidence of plagiarism and falsified data using CrossCheck software. This encompasses the following:
• multiple submission (i.e. to several journals at the same time)
• redundant publication (i.e. when the same data are published repeatedly, especially when articles contain an unacceptable degree of overlap but some original data, or in the case of the first time data are published (followed by subsequent redundant publications) when retraction would deprive readers of potentially useful data)
• reviewer misconduct (e.g. a reviewer making use of material obtained during review)
• changes to authorship after publication due to discovery of guest or ghost authors
• deliberate omission of funding or competing interest information.
Retractions Despite vigorous peer-review, it is possible that a paper that is fraudulent in some manner may be published. If this is discovered, it will immediately be retracted and appropriate steps will be taken to notify readers of the journal, and the authors’ institution. Retractions will include the word ‘Retraction’ in the title, so that they are identified as such on indexing systems, for example, PubMed.
The Journal has a duty to publish corrections (errata) when errors could affect the interpretation of data or information, whatever the cause of the error (i.e. arising from author or publisher errors). It is important to set the scientific record straight.
The title of the Erratum will include the words 'Erratum'. They are published on a numbered page (print and electronic) and are listed in the Journal's table of contents. They will cite the original article and be linked to it, so that indexing and abstracting services are able to identify and link to both the erratum and the original paper. Reasons for publishing an Erratum are clearly stated.
7. FURTHER INFORMATION
Proofs will be sent to the author for checking. This stage is to be used only to correct errors that may have been introduced during the typesetting process. Prompt return of the corrected proofs, preferably within two days of receipt, will facilitate expeditious online publication via Wiley’s EarlyView facility.
Free access to the final PDF offprint or your article will be available via Author Services. Please therefore sign up for Author Services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers.
Reviews in Medical Virology does not impose page charges.